Most Popular Stories
Events
- 8th Pharma/Bio Accounting and Reporting Congress
March 19 – 21, 2012 - ABA Wealth Management and Trust Conference
March 14 - 16, 2012 — Westin Kierland, Scottsdale, AZ - Investment Consultants Forum
March 2, 2012 — The Crowne Plaza Times Square, New York, NY - ABA Risk Management Forum
May 2 - 4, 2012 — Loews New Orleans, New Orleans, LA
Sponsored Links
FEATURES >> Highest Paid Bank CEOs | Top 10 Financial Failures of 2011
TOPICS >> MF Global | Occupy Wall Street | Dodd-Frank | Top Banks: GS C BAC JPM WFC MS
Latest News
Free Newsletter
FierceFinance is the financial services daily monitor, with news covering the banking industry, asset management, capital markets and SEC regulations. Sign up today!
Why Lehman Brothers really went belly up
"The Wall Street equivalent of a coroner's report." That's what the New York Times calls the 2,200 page tome delivered by bank examiner Anton Valukas about the demise of Lehman Brothers (Lehman Brothers news). It's something of a bombshell and the legal ramifications, at least at the civil level, may well be severe, as it accuses the likes of Dick Fuld (Richard Fuld news) with "manipulation" and "at least grossly negligent."
The reports found that Lehman "used what amounted to financial engineering to temporarily shuffle $50 billion of troubled assets off its books in the months before its collapse in September 2008 to conceal its dependence on leverage, or borrowed money. Senior Lehman executives, as well as the bank's accountants at Ernst & Young, were aware of the moves." Fuld signed off on them. In addition, JPMorgan Chase (NYSE: JPM) and Citigroup (NYSE: C) contributed to the liquidity crunch at Lehman by asking for more collateral.
The report details the bank's "Repo 105" ploy, the main method of masking the troubled securities. Fuld's lawyer told the paper he "did not know what those transactions were--he didn't structure or negotiate them, nor was he aware of their accounting treatment." Another executive wrote this in email about Repo 105: "I am very aware...it is another drug we're on."
For more:
- here's the article
Related Articles:
Where in the world is Erin Callan?
Another bad bet by Lehman Brothers: Art?
JPMorgan at risk in Lehman controversy?
Paulson's real mistake
Related Stories
- Banks face severe revenue drought
- Can quarterly window dressing by big banks be stopped?
- Big day approaches for Lehman Brothers
- What to make of Lehman's good bank/bad bank idea
- Compensation permanently lowered
- Jefferies battles rumors
- MF Global is gravy train for lawyers
- Roubini tweets about the next MF Global
- $600 million still missing from MF Global
- Corzine steps down, lawyers up
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site Map
| EditorsTHE FIERCEMARKETS NETWORKFierceEnergy | FierceSmartGrid | FierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceHealthPayer | FiercePracticeManagement | FierceEMR | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceGovernment | FierceHomelandSecurity | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceMedicalDevices | FierceDrugDelivery | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceEnterpriseCommunications | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe | FierceCable© 2011 FierceMarkets. All rights reserved. |
![]() |



